Maitreya Medicare Board of Directors

Get the latest insights into the leadership at Maitreya Medicare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Narendra Singh TanwarChairman cum Managing Director
Pranav Rohit ThakerWhole Time Director
Vimalkumar Natverlal PatelWhole Time Director
Hardik PatelNon Executive Independent Director
Abha SuranaNon Executive Independent Director
Kashish SuranaCompany Secretary & Compliance Officer

Maitreya Medicare Share price

MAITREYA

167.95

0.65 (0.39%)
Last updated on 23 Apr, 2026 | 15:29 IST
Today's High

167.95

Today's Low

161.90

52 Week Low

152.70

52 Week High

329.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Maitreya Medicare FAQs

The board at Maitreya Medicare consists of experienced professionals, including Narendra Singh Tanwar, Pranav Rohit Thaker, and others, overseeing the company’s strategic and corporate governance.

Directors at Maitreya Medicare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Narendra Singh Tanwar is the current chairman at Maitreya Medicare.

Executive directors at Maitreya Medicare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Maitreya Medicare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Maitreya Medicare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost